Your browser doesn't support javascript.
loading
Molecular landmarks of tumor hypoxia across cancer types.
Bhandari, Vinayak; Hoey, Christianne; Liu, Lydia Y; Lalonde, Emilie; Ray, Jessica; Livingstone, Julie; Lesurf, Robert; Shiah, Yu-Jia; Vujcic, Tina; Huang, Xiaoyong; Espiritu, Shadrielle M G; Heisler, Lawrence E; Yousif, Fouad; Huang, Vincent; Yamaguchi, Takafumi N; Yao, Cindy Q; Sabelnykova, Veronica Y; Fraser, Michael; Chua, Melvin L K; van der Kwast, Theodorus; Liu, Stanley K; Boutros, Paul C; Bristow, Robert G.
Afiliação
  • Bhandari V; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Hoey C; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Liu LY; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Lalonde E; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Ray J; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Livingstone J; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Lesurf R; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Shiah YJ; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Vujcic T; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Huang X; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Espiritu SMG; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Heisler LE; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Yousif F; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Huang V; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Yamaguchi TN; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Yao CQ; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Sabelnykova VY; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Fraser M; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Chua MLK; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • van der Kwast T; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Liu SK; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Boutros PC; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Bristow RG; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Nat Genet ; 51(2): 308-318, 2019 02.
Article em En | MEDLINE | ID: mdl-30643250
ABSTRACT
Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant metastasis, but the molecular hallmarks of tumor hypoxia remain poorly defined. To fill this gap, we quantified hypoxia in 8,006 tumors across 19 tumor types. In ten tumor types, hypoxia was associated with elevated genomic instability. In all 19 tumor types, hypoxic tumors exhibited characteristic driver-mutation signatures. We observed widespread hypoxia-associated dysregulation of microRNAs (miRNAs) across cancers and functionally validated miR-133a-3p as a hypoxia-modulated miRNA. In localized prostate cancer, hypoxia was associated with elevated rates of chromothripsis, allelic loss of PTEN and shorter telomeres. These associations are particularly enriched in polyclonal tumors, representing a constellation of features resembling tumor nimbosus, an aggressive cellular phenotype. Overall, this work establishes that tumor hypoxia may drive aggressive molecular features across cancers and shape the clinical trajectory of individual tumors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Hipóxia Tumoral / Hipóxia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Hipóxia Tumoral / Hipóxia Idioma: En Ano de publicação: 2019 Tipo de documento: Article